Glaukos Corporation

GKOS Healthcare Medical Devices

Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024. In the quarter to June 2026, revenue grew 49.5%, EPS grew 8.82%, free cash flow grew 211.8% and total debt fell 2.15%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

164.84 0.76 −0.46%
Market cap
$9.8B
P/E
0.0×
Fwd P/E
−139×
Dividend yield
—
F-score
3/9
Altman Z
15.20
Beneish M
−2.96
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
278.76 318.92 295.43 352.70 414.05 404.37 173.98 140.49 119.01 95.84
Receivables
108.61 60.74 39.85 36.07 33.44 36.06 38.42 18.67 16.66 14.31
Inventory
63.56 57.68 41.99 37.84 23.01 15.81 42.58 13.28 11.22 6.84
Total current assets
474.98 449.79 395.46 443.86 486.13 469.44 262.88 176.57 149.46 120.02
Property, Plant, Equpment (Net)
113.25 97.87 103.21 94.40 68.97 24.01 22.06 19.15 11.79 7.59
Goodwill and Intangible Assets (Total)
208.63 329.58 349.09 374.00 398.92 423.83 448.74 — 3.15 6.57
Long Term Assets (Tax, Deferred)
— — — — — — — 0.21 0.24 —
Long-term assets (Other)
25.69 25.45 21.33 17.69 18.52 16.77 14.98 11.04 1.20 0.19
Total non-current assets
418.50 524.96 544.95 558.52 563.57 536.06 555.52 30.40 16.38 14.35
Total Assets
893.49 974.76 940.41 1,002.38 1,049.70 1,005.50 818.40 206.97 165.84 134.37
Accounts Payable
24.62 13.03 13.44 14.40 7.33 4.37 5.78 6.29 6.24 2.97
Accrued Expenses
76.65 62.10 60.57 57.96 56.03 45.33 51.92 23.96 20.45 13.91
Current Revenue (Deferred)
— — — — — — 0.00 0.12 0.10 0.06
Total current liabilities
101.28 75.13 74.01 72.36 63.36 49.70 57.70 30.37 26.79 16.94
Long Term Debt (Total)
68.11 69.46 353.31 353.57 352.73 250.11 58.44 — — —
Long Term Tax Liability (Deferred)
0.44 6.93 7.14 7.26 7.32 10.51 9.63 0.00 0.00 —
Non-current Liabilities (Other)
31.74 22.37 13.75 10.28 9.49 7.03 5.17 2.75 0.85 0.16
Total non-current liabilities
136.06 132.70 404.63 400.02 399.19 288.35 87.43 2.75 0.85 0.16
Total liabilities
237.33 207.83 478.65 472.38 462.55 338.05 145.13 33.11 27.63 17.10
Additional Paid In Capital
1,586.06 1,509.83 1,059.75 997.47 952.43 976.59 861.74 378.35 331.07 308.82
Common Stock (Net)
0.06 0.06 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.03
Retained Earnings
(933.13) (745.44) (599.07) (464.41) (365.21) (310.06) (189.71) (205.13) (192.18) (192.09)
Treasury Stock
0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13
Common Equity (Total)
656.16 766.93 461.77 530.00 587.15 667.45 673.27 173.86 138.20 117.27
Shareholders Equity (Total)
656.16 766.93 461.77 530.01 587.15 667.45 673.27 173.86 138.20 117.27
Shareholders Equity and Liabilities (Total)
893.49 974.76 940.41 1,002.38 1,049.70 1,005.50 818.40 206.97 165.84 134.37
Shares (Common)
57.51 56.44 49.12 47.75 46.97 45.25 43.50 36.11 34.62 33.94
Shareholders Equity (Tangible)
447.53 437.35 112.68 156.00 188.24 243.62 224.53 173.86 135.06 110.71
Net Debt
(210.65) (249.45) 57.88 0.88 (61.33) (154.26) (115.55) (140.49) (119.01) (95.84)
Total Debt
68.11 69.46 353.31 353.57 352.73 250.11 58.44 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates